Clinical Trial Update: Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event

View source ↗

Summary

A completed clinical trial evaluated whether imaging with iodine-123 labeled metaiodobenzylguanidine (I-123 MIBG) can identify congestive heart failure patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Iodine-123 metaiodobenzylguanidine (I-123 MIBG) (metaiodobenzylguanidine)

Snippet

Sponsor: GE Healthcare | Conditions: Congestive Heart Failure | Status: COMPLETED | Results posted: 2017-04-26